Classification of Diseases in General Medicine- Crimson Publishers

To diagnose is to collect data to analyse and interpret them, which allows evaluating a certain condition. In medicine, therefore, a diagnosis seeks to reveal the manifestation of a disease from observing and analysing its symptoms. However, this observation of the signs of a disorder to recognize a disease is mediated by the theoretical framework in which we move [1].

Students learn, generally in a self-taught way, that there is a clinical method and that it consists of the scientific method applied to the individual care of the sick. That is, do a history of the disease that the patient tells, explore and perform complementary tests to collect objective data, build hypotheses about which organs are affected, and what disease causes it. However, it usually happens that, after being dazzled by the brightness of such a method in the hospital, when the doctor comes to work in general medicine, he begins to face the fact that, a certain part of the patients have diseases which cannot be fit in any classifications.

https://crimsonpublishers.com/rmes/fulltext/RMES.000691.php

For more open access journals in crimson publishers Please click on link: https://crimsonpublishers.com

For more articles on Research in Medical & Engineering Sciences Please click on link: https://crimsonpublishers.com/rmes/

Comments

The Malachite Wen-Myeloid Sarcoma- Crimson Publishers

The Malachite Wen-Myeloid Sarcoma- Crimson Publishers Contingent to World Health Organization (WHO) classification, myeloid sarcoma is denominated as a tumefaction comprised of myeloblasts amalgamated at an anatomical site divergent from the bone marrow which engenders distortion of normal tissue architecture. Generally, myeloid sarcoma is contemplated to be equivalent to and concurrent with acute myeloid leukaemia (AML), although lesions may occur in isolation. Additionally designated as granulocytic sarcoma, chloroma or extramedullary myeloid tumour, myeloid sarcoma categorically represents as a distinct tumefaction associated with architectural effacement of circumscribing soft tissue. Myeloid sarcoma may emerge as a de novo lesion or manifest as therapy related myeloid neoplasm or as disease progression within myeloproliferative neoplasm (MPN), myelodysplastic syndrome (MDS) or myelodysplastic / myeloproliferative neoplasm (MDS / MPN). In contrast, leukaemia cutis (LC) is...

Stimulus Activated Shape Switching in Shape Memory Materials with Tailor Able Start/Finish Temperature/ Time - Crimson Publishers

Stimulus Activated ShapeSwitching in Shape Memory Materials with Tailor Able Start/Finish Temperature/Time by Wei Min Huang* in Research in Medical & Engineering Sciences The shape memory effect (SME) refers to the phenomenon of shape recovery in a severely pre-deformed material , but only when a right stimulus is applied. The materials with the SME are called shape memory material (SMM), and typical stimuli include heat, chemical (including water/moisture), light, etc. Right now, the family of SMM has expended significantly, and covers a range of different types of materials, including alloy, polymer and ceramic etc. In general, the SME process includes two steps. The first step is to program the piece of SMM into a temporary shape (known as the programming process); and the second step is to apply the right stimulus for recovery (called the recovery process) with or without constraint applied. https://crimsonpublishers.com/rmes/fulltext/RMES.000515.php For mo...

Recent Developments of Decentralized Clinical Trial Technology in Korea- Crimson Publishers

Recent Developments of Decentralized Clinical Trial Technology in Korea- CrimsonPublishers Clinical trials are routinely performed on human participants to evaluate the safety and effectiveness of new treatments such as drugs and medical devices. Recent advances in Information and Communication Technology (ICT) have led to the development of Decentralized Clinical Trials (DCTs). DCTs allow participants to participate in various types of clinical trials without having to visit hospitals. Data collection and frequent interactions between participants and medical staff can be possible via remote monitoring environments. In addition, the costs and time for clinical trials conduction can be significantly reduced. The development of ICT-based DCT technologies has already initiated. However, the adoption of DCTs was facilitated by the coronavirus disease 2019 (COVID-19) pandemic. Interest in and research on DCTs has also grown in Korea. This study describes the present state of DCT ...

Crimson Publishers-Research in Medical & Engineering Sciences

Search This Blog